KLHL41
Basic information
Region (hg38): 2:169509702-169526258
Previous symbols: [ "KBTBD10" ]
Links
Phenotypes
GenCC
Source:
- nemaline myopathy 9 (Strong), mode of inheritance: AR
- severe congenital nemaline myopathy (Supportive), mode of inheritance: AR
- intermediate nemaline myopathy (Supportive), mode of inheritance: AD
- typical nemaline myopathy (Supportive), mode of inheritance: AD
- childhood-onset nemaline myopathy (Supportive), mode of inheritance: AD
- nemaline myopathy 9 (Moderate), mode of inheritance: AR
- nemaline myopathy 9 (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Nemaline myopathy 9 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 24268659 |
ClinVar
This is a list of variants' phenotypes submitted to
- Nemaline myopathy 9 (14 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLHL41 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 66 | 69 | ||||
missense | 138 | 148 | ||||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 12 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 1 | 4 | 2 | 7 | ||
non coding | 25 | 34 | ||||
Total | 14 | 7 | 143 | 100 | 12 |
Highest pathogenic variant AF is 0.0000197
Variants in KLHL41
This is a list of pathogenic ClinVar variants found in the KLHL41 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-169509786-C-T | not specified • Nemaline myopathy 9 | Benign (Feb 01, 2024) | ||
2-169509792-G-A | Nemaline myopathy 9 | Uncertain significance (Dec 09, 2021) | ||
2-169509793-G-A | Nemaline myopathy 9 • KLHL41-related disorder | Benign/Likely benign (Jan 10, 2024) | ||
2-169509800-G-A | Nemaline myopathy 9 | Uncertain significance (Jan 21, 2020) | ||
2-169509801-C-T | Inborn genetic diseases | Uncertain significance (Dec 13, 2023) | ||
2-169509811-G-C | Nemaline myopathy 9 | Likely benign (Sep 13, 2023) | ||
2-169509828-C-G | Nemaline myopathy 9 | Uncertain significance (Jul 01, 2022) | ||
2-169509830-C-T | Nemaline myopathy 9 | Uncertain significance (Mar 22, 2022) | ||
2-169509839-G-C | Nemaline myopathy 9 | Uncertain significance (Mar 13, 2022) | ||
2-169509843-G-C | Nemaline myopathy 9 | Uncertain significance (Oct 18, 2022) | ||
2-169509851-G-A | Nemaline myopathy 9 | Uncertain significance (Mar 29, 2022) | ||
2-169509851-G-T | Nemaline myopathy 9 | Uncertain significance (Jan 27, 2022) | ||
2-169509856-C-G | Nemaline myopathy 9 | Likely benign (Jul 30, 2022) | ||
2-169509861-ATGAGAAAAAATTCATCGATTGCAC-TGTCA | Likely pathogenic (Mar 06, 2020) | |||
2-169509877-C-T | Nemaline myopathy 9 | Likely benign (Feb 04, 2022) | ||
2-169509879-A-G | Nemaline myopathy 9 | Uncertain significance (Sep 21, 2021) | ||
2-169509880-T-C | Nemaline myopathy 9 | Likely benign (Mar 18, 2022) | ||
2-169509913-T-C | Nemaline myopathy 9 | Likely benign (Aug 01, 2022) | ||
2-169509923-T-C | Nemaline myopathy 9 | Likely benign (Dec 20, 2021) | ||
2-169509924-T-C | Nemaline myopathy 9 | Uncertain significance (Feb 13, 2019) | ||
2-169509931-G-T | Inborn genetic diseases | Uncertain significance (Jun 05, 2023) | ||
2-169509931-GTCAGC-G | Nemaline myopathy 9 | Pathogenic (Oct 17, 2022) | ||
2-169509942-GTCCTTACT-G | Nemaline myopathy 9 | Pathogenic (Jun 16, 2017) | ||
2-169509948-AC-CT | Nemaline myopathy 9 | Uncertain significance (Aug 30, 2023) | ||
2-169509953-C-T | Nemaline myopathy 9 | Uncertain significance (Oct 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLHL41 | protein_coding | protein_coding | ENST00000284669 | 6 | 16561 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000111 | 0.990 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.887 | 282 | 327 | 0.862 | 0.0000172 | 3991 |
Missense in Polyphen | 84 | 111.32 | 0.75457 | 1324 | ||
Synonymous | 1.17 | 103 | 119 | 0.863 | 0.00000629 | 1179 |
Loss of Function | 2.27 | 10 | 21.3 | 0.469 | 9.84e-7 | 299 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000307 | 0.000304 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000247 | 0.000246 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000984 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in skeletal muscle development and differentiation. Regulates proliferation and differentiation of myoblasts and plays a role in myofibril assembly by promoting lateral fusion of adjacent thin fibrils into mature, wide myofibrils. Required for pseudopod elongation in transformed cells. {ECO:0000250|UniProtKB:A2AUC9}.;
- Disease
- DISEASE: Nemaline myopathy 9 (NEM9) [MIM:615731]: An autosomal recessive form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination. NEM9 phenotype is highly variable, ranging from death in infancy due to lack of antigravity movements, to slowly progressive distal muscle weakness with preserved ambulation later in childhood. {ECO:0000269|PubMed:24268659}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.3
Haploinsufficiency Scores
- pHI
- 0.875
- hipred
- N
- hipred_score
- 0.455
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klhl41
- Phenotype
- growth/size/body region phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype;
Zebrafish Information Network
- Gene name
- klhl41a
- Affected structure
- skeletal muscle
- Phenotype tag
- abnormal
- Phenotype quality
- refractivity
Gene ontology
- Biological process
- striated muscle contraction;protein ubiquitination;myofibril assembly;regulation of lateral pseudopodium assembly;skeletal muscle cell differentiation;post-translational protein modification;sarcomere organization;regulation of myoblast differentiation;skeletal muscle fiber development;regulation of myoblast proliferation;regulation of skeletal muscle cell differentiation
- Cellular component
- ruffle;nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;cytoskeleton;plasma membrane;pseudopodium;M band;Cul3-RING ubiquitin ligase complex;sarcoplasmic reticulum membrane
- Molecular function
- protein binding